Analyst Downgrades – NYSE:EW – Edwards Lifesciences (NYSE:EW) Stock Gets Downgraded By Northland Securities from Outperform to Market Perform

ME Staff
-
0

Analyst Ratings For NYSE:EW – Edwards Lifesciences (NYSE:EW)

Today, NYSE:EW – Edwards Lifesciences (NYSE:EW) stock was downgraded by Northland Securities from Outperform to Market Perform.

Some recent analyst ratings include

  • 4/25/2018-Northland Securities was Downgraded by analysts at Northland Securities from a “Outperform ” rating to a ” Market Perform” rating.
  • 4/10/2018-SunTrust Banks Reiterated Rating of Buy.
  • 3/20/2018-Cowen Reiterated Rating of Buy.
  • 2/2/2018-Guggenheim Reiterated Rating of Buy.
  • 2/2/2018-Stifel Nicolaus Reiterated Rating of Buy.

Recent Insider Trading Activity For NYSE:EW – Edwards Lifesciences (NYSE:EW)
NYSE:EW – Edwards Lifesciences (NYSE:EW) has insider ownership of 1.84% and institutional ownership of 83.02%.

  • On 4/16/2018 Larry L. Wood, VP, sold 6,300 with an average share price of $138.97 per share and the total transaction amounting to $875,511.00.
  • On 4/11/2018 Jean-Luc M. Lemercier, VP, sold 5,633 with an average share price of $139.42 per share and the total transaction amounting to $785,352.86.
  • On 4/4/2018 Donald E. Bobo, Jr., VP, sold 4,000 with an average share price of $134.78 per share and the total transaction amounting to $539,120.00.
  • On 4/4/2018 Scott B Ullem, CFO, sold 25,000 with an average share price of $137.17 per share and the total transaction amounting to $3,429,250.00.
  • On 3/29/2018 Donald E Bobo Jr, VP, sold 5,300 with an average share price of $138.58 per share and the total transaction amounting to $734,474.00.
  • On 3/28/2018 Scott B Ullem, CFO, sold 25,000 with an average share price of $137.33 per share and the total transaction amounting to $3,433,250.00.
  • On 3/21/2018 Michael A Mussallem, CEO, sold 32,800 with an average share price of $139.74 per share and the total transaction amounting to $4,583,472.00.

Recent Trading Activity for NYSE:EW – Edwards Lifesciences (NYSE:EW)
Shares of NYSE:EW – Edwards Lifesciences closed the previous trading session at 127.09 down -7.58 5.63% with 1401263 shares trading hands.